Medtronic Plc (NYSE: MDT) has initiated a voluntary recall to customers related to the risk associated with tip damage caused by guidewire prolapse in its 6 French (6Fr) TurboHawk Plus Directional ...
Medtronic has recalled 686 TurboHawk Plus Directional Atherectomy Systems because there is a risk that the guidewire within the catheter may move downward or prolapse during use, which may damage the ...
Medtronic and the FDA are expanding the reach of a Class I recall handed down in January for the medtech giant’s catheter designed to clear out clogged arteries. The previous recall covered more than ...
Study Confirms Effectiveness of Directional Atherectomy with SilverHawk ™ and TurboHawk ™ Devices as a Frontline Therapy when Treating PAD DEFINITIVE LE study confirms that directional atherectomy ...
The TurboHawk features a four angled super cutter blade that are designed to provide an efficient directional atherectomy tool for above the knee interventions including severally calcified lesions ...
Largest directional atherectomy study with independent, core lab analysis demonstrates high limb salvage in patients with critical limb ischemia and strong patency rates in both diabetic and ...
Medtronic and VIVA Physicians announced the enrollment of the first patient in the REALITY study of patients with severely calcified lesions in the femoropopliteal artery. The trial will gauge ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Medtronic is recalling its HawkOne ...
Medtronic ($MDT) announced the U.S. launch of its HawkOne directional atherectomy system, for surgical treatment of peripheral artery disease, or blocked and ...
DUBLIN -- Medtronic plc enhances its leading directional atherectomy portfolio with the U.S. launch of the HawkOne(TM) directional atherectomy system. The HawkOne system provides physicians with a ...
LAS VEGAS--(BUSINESS WIRE)-- Covidien (NYS: COV) , a leading global provider of healthcare products, today announced final 12-month results from its DEFINITIVE LE (Determination of Effectiveness of ...